Literature DB >> 19043526

Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.

Kenneth J Pienta1, Natalie McGregor, Robert Axelrod, David E Axelrod.   

Abstract

We propose that there is an opportunity to devise new cancer therapies based on the recognition that tumors have properties of ecological systems. Traditionally, localized treatment has targeted the cancer cells directly by removing them (surgery) or killing them (chemotherapy and radiation). These modes of therapy have not always been effective because many tumors recur after these therapies, either because not all of the cells are killed (local recurrence) or because the cancer cells had already escaped the primary tumor environment (distant recurrence). There has been an increasing recognition that the tumor microenvironment contains host noncancer cells in addition to cancer cells, interacting in a dynamic fashion over time. The cancer cells compete and/or cooperate with nontumor cells, and the cancer cells may compete and/or cooperate with each other. It has been demonstrated that these interactions can alter the genotype and phenotype of the host cells as well as the cancer cells. The interaction of these cancer and host cells to remodel the normal host organ microenvironment may best be conceptualized as an evolving ecosystem. In classic terms, an ecosystem describes the physical and biological components of an environment in relation to each other as a unit. Here, we review some properties of tumor microenvironments and ecological systems and indicate similarities between them. We propose that describing tumors as ecological systems defines new opportunities for novel cancer therapies and use the development of prostate cancer metastases as an example. We refer to this as "ecological therapy" for cancer.

Entities:  

Year:  2008        PMID: 19043526      PMCID: PMC2582164          DOI: 10.1593/tlo.08178

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  89 in total

1.  Mutation selection and the natural history of cancer.

Authors:  J Cairns
Journal:  Nature       Date:  1975-05-15       Impact factor: 49.962

Review 2.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

Review 3.  Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect".

Authors:  Donald S Coffey; Robert H Getzenberg; Theodore L DeWeese
Journal:  JAMA       Date:  2006-07-26       Impact factor: 56.272

Review 4.  Stem cells from adipose tissue allow challenging new concepts for regenerative medicine.

Authors:  Marco N Helder; Marlene Knippenberg; Jenneke Klein-Nulend; Paul I J M Wuisman
Journal:  Tissue Eng       Date:  2007-08

Review 5.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

Review 6.  Anti-CTLA4 monoclonal antibody Ipilimumab in the treatment of metastatic melanoma: recent findings.

Authors:  Marko Lens; Pier F Ferrucci; Alessandro Testori
Journal:  Recent Pat Anticancer Drug Discov       Date:  2008-06       Impact factor: 4.169

7.  Treatment of bone metastases and bone pain with bisphosphonates.

Authors:  Allan Lipton
Journal:  Support Cancer Ther       Date:  2007-01-01

8.  Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.

Authors:  A F Olumi; G D Grossfeld; S W Hayward; P R Carroll; T D Tlsty; G R Cunha
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

9.  Macrophages in human breast disease: a quantitative immunohistochemical study.

Authors:  P M Kelly; R S Davison; E Bliss; J O McGee
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

10.  cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin.

Authors:  Der-Chih Yang; Huey-Jen Tsay; Shan-Yang Lin; Shih-Hwa Chiou; Mei-Jane Li; Tai-Jay Chang; Shih-Chieh Hung
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

View more
  73 in total

Review 1.  Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.

Authors:  Sudhir Srivastava; Brian J Reid; Sharmistha Ghosh; Barnett S Kramer
Journal:  J Cell Physiol       Date:  2016-04-29       Impact factor: 6.384

Review 2.  Ecological paradigms to understand the dynamics of metastasis.

Authors:  Sarah R Amend; Sounak Roy; Joel S Brown; Kenneth J Pienta
Journal:  Cancer Lett       Date:  2015-10-10       Impact factor: 8.679

3.  Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Authors:  Mark Robertson-Tessi; Robert J Gillies; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

Review 4.  Tumorigenesis: it takes a village.

Authors:  Doris P Tabassum; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2015-07-02       Impact factor: 60.716

Review 5.  Targeting the tumour stroma to improve cancer therapy.

Authors:  Kenneth C Valkenburg; Amber E de Groot; Kenneth J Pienta
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

6.  Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.

Authors:  Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Clin Cancer Res       Date:  2011-06-15       Impact factor: 12.531

7.  An Open-Label Study of the Safety and Efficacy of Tag-7 Gene-Modified Tumor Cells-Based Vaccine in Patients with Locally Advanced or Metastatic Malignant Melanoma or Renal Cell Cancer.

Authors:  Aleksei Viktorovich Novik; Anna Borisovna Danilova; Maksim Ivanovich Sluzhev; Tatiana Leonidovna Nehaeva; Sergei Sergeevich Larin; Dmitry Viktorovich Girdyuk; Svetlana Anatolevna Protsenko; Anna Igorevna Semenova; Aleksei Olegovich Danilov; Vladimir Mikhailovich Moiseyenko; Georgii Pavlovich Georgiev; Irina Aleksandrovna Baldueva
Journal:  Oncologist       Date:  2020-04-07

8.  Dissecting heterogeneous cell populations across drug and disease conditions with PopAlign.

Authors:  Sisi Chen; Paul Rivaud; Jong H Park; Tiffany Tsou; Emeric Charles; John R Haliburton; Flavia Pichiorri; Matt Thomson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-30       Impact factor: 11.205

9.  Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Authors:  Laura J Esserman; Ian M Thompson; Brian Reid; Peter Nelson; David F Ransohoff; H Gilbert Welch; Shelley Hwang; Donald A Berry; Kenneth W Kinzler; William C Black; Mina Bissell; Howard Parnes; Sudhir Srivastava
Journal:  Lancet Oncol       Date:  2014-05       Impact factor: 41.316

10.  A general reaction-diffusion model of acidity in cancer invasion.

Authors:  Jessica B McGillen; Eamonn A Gaffney; Natasha K Martin; Philip K Maini
Journal:  J Math Biol       Date:  2013-03-28       Impact factor: 2.259

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.